Next-Generation Sequencing in Translational Sarcoma Research: Biological Insights and Emerging Directions

Sarcomas are rare and heterogeneous malignancies for which molecular diagnostics increasingly complement histopathology, immunohistochemistry, FISH, and RT-PCR. This review summarizes the main research applications of next-generation sequencing (NGS) in sarcoma, with particular attention to mutation and variant discovery, fusion detection, biomarker development, assay validation, multi-omics integration, and the boundaries between exploratory research and clinical implementation.

  • Published in:
    Current Oncology Reports
  • Type:
    Article
  • Authors:
    De Vita, Alessandro; Violani, Sara; Miserocchi, Giacomo; Xerxa, Elena; Bajorath, Jürgen; Vanni, Silvia
  • Year:
    2026

Citation information

De Vita, Alessandro; Violani, Sara; Miserocchi, Giacomo; Xerxa, Elena; Bajorath, Jürgen; Vanni, Silvia: Next-Generation Sequencing in Translational Sarcoma Research: Biological Insights and Emerging Directions, Current Oncology Reports, 2026, 28, 1, September, Springer Science and Business Media LLC, DeVita.etal.2026a,

Associated Lamarr Researchers

LAMARR Person Xerxa Elena - Lamarr Institute for Machine Learning (ML) and Artificial Intelligence (AI)

Dr. Elena Xerxa

Scientific Coordinator Life Sciences & Health to the profile
LAMARR Person 500x500 Bajorath 2 - Lamarr Institute for Machine Learning (ML) and Artificial Intelligence (AI)

Prof. Dr. Jürgen Bajorath

Area Chair Life Sciences & Health to the profile